Bill Text: OH SB64 | 2009-2010 | 128th General Assembly | Introduced


Bill Title: To require certain health care policies, contracts, agreements, and plans, as well as the state's Medicaid program, to provide benefits for colorectal examinations and laboratory tests for cancer.

Spectrum: Moderate Partisan Bill (Democrat 5-1)

Status: (Introduced - Dead) 2009-03-04 - To Insurance, Commerce, & Labor [SB64 Detail]

Download: Ohio-2009-SB64-Introduced.html
As Introduced

128th General Assembly
Regular Session
2009-2010
S. B. No. 64


Senator Coughlin 

Cosponsors: Senators Fedor, Miller, D., Morano, Sawyer, Turner 



A BILL
To enact sections 1751.69, 3923.651, and 5111.0210 of1
the Revised Code to require certain health care2
policies, contracts, agreements, and plans, as 3
well as the state's Medicaid program, to provide 4
benefits for colorectal examinations and 5
laboratory tests for cancer.6


BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

       Section 1. That sections 1751.69, 3923.651, and 5111.0210 of 7
the Revised Code be enacted to read as follows:8

       Sec. 1751.69.  (A) Notwithstanding section 3901.71 of the9
Revised Code, each individual or group health insuring corporation10
policy, contract, or agreement providing basic health care11
services that is delivered, issued for delivery, or renewed in12
this state shall provide benefits for the expenses of colorectal 13
cancer examinations and laboratory tests for colorectal cancer for 14
any nonsymptomatic individual who is either of the following:15

       (1) Fifty years of age or older;16

       (2) Less than fifty years of age and at high risk for17
colorectal cancer due to one of the following:18

       (a) A personal history of colorectal cancer or adenomatous 19
polyps;20

       (b) A personal history of chronic inflammatory bowel disease, 21
such as Crohn's disease or ulcerative colitis;22

       (c) A family history of colorectal cancer or polyps, 23
determined by cancer or polyps in a first degree relative less 24
than sixty years of age or two or more first degree relatives of 25
any age;26

       (d) A known family history of hereditary colorectal cancer 27
syndromes such as familial adenomatous polyposis or hereditary 28
nonpolyposis colon cancer.29

       (B) The benefits provided under division (A) of this section 30
shall include coverage of all of the following:31

       (1) Flexible sigmoidoscopy every five years;32

       (2) Colonoscopy every ten years;33

       (3) Double contrast barium enema every five years;34

       (4) CT colonography every five years;35

       (5) A stool DNA test with high sensitivity for cancer every 36
five years or one of the following screening tests annually:37

       (a) Guaiac-based fecal occult blood test with high test 38
sensitivity for cancer;39

       (b) Fecal immunochemical test with high test sensitivity for 40
cancer;41

       (c) Any combination of the most reliable, medically 42
recognized screening tests available.43

       (C) The benefits provided under division (A) of this section44
shall be subject to all terms, conditions, restrictions, 45
exclusions, and limitations that apply to any other coverage 46
under the policy, contract, or agreement for services performed 47
by participating and nonparticipating providers. Nothing in this 48
section shall be construed as requiring reimbursement to a 49
provider or facility providing the examination or test that does 50
not have a health care contract with the health insuring 51
corporation, or as prohibiting a health insuring corporation that 52
does not have a health care contract with the provider or 53
facility providing the examination or test from negotiating a 54
single case or other agreement for coverage.55

       Sec. 3923.651. (A) Notwithstanding section 3901.71 of the56
Revised Code, each policy of individual or group sickness and57
accident insurance that is delivered, issued for delivery, or58
renewed in this state and each public employee benefit plan that 59
is established or modified in this state shall provide benefits 60
for the expenses of colorectal cancer examinations and laboratory 61
tests for colorectal cancer for any nonsymptomatic individual who 62
is either of the following:63

       (1) Fifty years of age or older;64

       (2) Less than fifty years of age and at high risk for65
colorectal cancer due to one of the following:66

       (a) A personal history of colorectal cancer or adenomatous 67
polyps;68

       (b) A personal history of chronic inflammatory bowel disease, 69
such as Crohn's disease or ulcerative colitis;70

       (c) A family history of colorectal cancer or polyps, 71
determined by cancer or polyps in a first degree relative less 72
than sixty years of age or two or more first degree relatives of 73
any age;74

       (d) A known family history of hereditary colorectal cancer 75
syndromes such as familial adenomatous polyposis or hereditary 76
nonpolyposis colon cancer.77

       (B) The benefits provided under division (A) of this section78
shall include coverage of all of the following:79

       (1) Flexible sigmoidoscopy every five years;80

       (2) Colonoscopy every ten years;81

       (3) Double contrast barium enema every five years;82

       (4) CT colonography every five years;83

       (5) A stool DNA test with high sensitivity for cancer every 84
five years or one of the following screening tests annually:85

       (a) Guaiac-based fecal occult blood test with high test 86
sensitivity for cancer;87

       (b) Fecal immunochemical test with high test sensitivity for 88
cancer;89

       (c) Any combination of the most reliable, medically 90
recognized screening tests available.91

       (C) The benefits provided under division (A) of this section92
shall be subject to all terms, conditions, restrictions, 93
exclusions, and limitations that apply to any other coverage under 94
the policy or plan for services performed by participating and 95
nonparticipating providers. Nothing in this section shall be 96
construed as requiring reimbursement to a provider or facility 97
providing the examination or test that does not have a health care 98
contract with the entity issuing the policy or plan, or as 99
prohibiting the entity issuing a policy or plan that does not have 100
a health care contract with the provider or facility providing the 101
examination or test from negotiating a single case or other 102
agreement for coverage.103

       (D) This section does not apply to any policy that provides104
coverage for specific diseases or accidents only, or to any105
hospital indemnity, medicare supplement, or other policy that106
offers only supplemental benefits.107

       Sec. 5111.0210. (A) The medicaid program shall cover108
colorectal cancer examinations and laboratory tests for colorectal109
cancer for any nonsymptomatic medicaid recipient who is either of 110
the following:111

       (1) Fifty years of age or older;112

       (2) Less than fifty years of age and at high risk for113
colorectal cancer due to one of the following:114

       (a) A personal history of colorectal cancer or adenomatous 115
polyps;116

       (b) A personal history of chronic inflammatory bowel disease, 117
such as Crohn's disease or ulcerative colitis;118

       (c) A family history of colorectal cancer or polyps, 119
determined by cancer or polyps in a first degree relative less 120
than sixty years of age or in two or more first degree relatives 121
of any age;122

       (d) A known family history of hereditary colorectal cancer 123
syndromes such as familial adenomatous polyposis or hereditary 124
nonpolyposis colon cancer.125

       (B) The coverage provided under division (A) of this section126
shall include coverage of all of the following:127

       (1) Flexible sigmoidoscopy every five years;128

       (2) Colonoscopy every ten years;129

       (3) Double contrast barium enema every five years;130

       (4) CT colonography every five years;131

       (5) A stool DNA test with high sensitivity for cancer every 132
five years or one of the following screening tests annually:133

       (a) Guaiac-based fecal occult blood test with high test 134
sensitivity for cancer;135

       (b) Fecal immunochemical test with high test sensitivity for 136
cancer;137

       (c) Any combination of the most reliable, medically 138
recognized screening tests available.139

feedback